Derek Cole
Investor Relations, Investor Relations Advisory Solutions
Replay available
Longeveron Inc. (NASDAQ: LGVN) Q2 2026 earnings conference call, held 2026-08-12. Replay captured from the company's public earnings webcast.

Investor Relations, Investor Relations Advisory Solutions
Chief Executive Officer
Chief Medical Officer
Chief Financial Officer
Co-Founder, Chief Science Officer and Executive Chairman
Analyst, H.C. Wainwright
Analyst, Roth Capital Partners
Analyst, Maxim Group
Watch the replay and follow the connected company analysis, news, and investor updates for Longeveron Inc..
WEBVTT 00:00:00.031 -- 00:00:02.973 Good day and welcome to the Longeveron 00:00:02.973 -- 00:00:07.115 2026 Second Quarter Financial Results Conference Call. 00:00:07.115 -- 00:00:12.139 If you would like to ask a question today, please press star 1 on your telephone keypad. 00:00:12.139 -- 00:00:15.901 A confirmation tone will indicate your line is in the question queue. 00:00:15.901 -- 00:00:19.423 You may press star 2 to remove yourself from the queue. 00:00:19.423 -- 00:00:23.726 For participants using speaker equipment, it may be necessary to pick up the handset 00:00:23.726 -- 00:00:28.909 before pressing the star keys. Please be advised that today's conference 00:00:28.909 -- 00:00:34.302 is being recorded. I would now like to hand the call over to Derek Cole of Investor Relations 00:00:34.302 -- 00:00:38.343 Advisory Solutions. Please go ahead, sir. 00:00:38.565 -- 00:00:42.867 Thank you, Rachelle. Good afternoon, everyone, and thank you for joining us today to 00:00:42.867 -- 00:00:47.950 review Longeveron's 2026 second quarter financial results and business update. 00:00:47.950 -- 00:00:51.832 After the U.S. markets closed today, we issued a press release with financial results 00:00:51.832 -- 00:00:55.995 for the second quarter, which can be found under the investor section of the Longeveron 00:00:55.995 -- 00:00:57.725 website. 00:00:57.725 -- 00:01:01.246 On the call today are Stephen Willard, Chief Executive Officer, Dr. 00:01:01.246 -- 00:01:06.527 Joshua Hare, Co-Founder, Chief Science Officer, and Executive Chairman of the Board, 00:01:06.527 -- 00:01:11.729 Dr. Nataliya Agafonova, Chief Medical Officer, Devin Blass, Chief Technology 00:01:11.729 -- 00:01:15.450 Officer, and Marie Washburn, Chief Financial Officer. 00:01:15.450 -- 00:01:19.230 As a ...